Pallotti S, Paolucci D, Santoro S, Rotolo A
Minerva Med. 1978 Nov 14;69(55):3779-83.
Metabolic Clearance Rate (MCR) and half life of 125I Human Growth Hormone (HGH) have been studied in hepatopathic patients. A clear reduction of MCR and a prolongation of HGH half life have been found in all patients examined. After a 30 day therapy with crude liver extract (F.U. VIII ed.) both MCR and HGH half life have shown a tendency towards normalization. These findings are in agreement with the marked improvement of the clinical state of the patients and with the normalization of the laboratory indexes.
对肝病患者的125I人生长激素(HGH)的代谢清除率(MCR)和半衰期进行了研究。在所有接受检查的患者中,均发现MCR明显降低,HGH半衰期延长。在用粗制肝提取物(第八版F.U.)进行30天治疗后,MCR和HGH半衰期均呈现出趋于正常化的趋势。这些发现与患者临床状态的显著改善以及实验室指标的正常化相一致。